TD Asset Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.81M Buy
2020
Q1
Sell
2019
Q4
$74K Sell
2019
Q3
$131K Sell
2019
Q2
$185K Buy
2019
Q1
$190K Buy
2018
Q4
$173K Buy
2018
Q3
$399K Buy
2018
Q2
$491K Buy
2018
Q1
$511K Buy
2017
Q3
Sell
2017
Q2
$130K Sell
2017
Q1
$499K Buy
2016
Q4
$318K Sell
2016
Q3
$387K Buy